Pancreatic cancer is four diseases, each with new treatment possibilities

February 24, 2016
Axial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domain

An international team led by Australian researchers has studied the genetics of pancreatic cancer, revealing it is actually four separate diseases, each with different genetic triggers and survival rates, paving the way for more accurate diagnoses and treatments.

The significant findings also include 10 genetic pathways at the core of transforming normal tissue into cancerous tumours. Some of these processes are related to bladder and lung cancers, opening up the possibility of using treatments for these cancers to also treat pancreatic cancer.

The study was led by Prof Sean Grimmond, formerly of The University of Queensland's Institute for Molecular Bioscience (IMB), now the Director of Research & The Bertalli Chair in Cancer Medicine, University of Melbourne Centre for Cancer Research.

Published today in the international journal Nature, the research team included Professor Andrew Biankin from the Garvan Institute of Medical Research and the University of New South Wales and bioinformatician Dr Nicola Waddell, now based at QIMR Berghofer Medical Research.

Over seven years, scientists analysed the genomes of 456 pancreatic tumours to determine the core processes that are damaged when normal pancreatic tissues change into aggressive cancers.

Professor Grimmond said there was an urgent need for more knowledge about the genetic causes of pancreatic cancer, with most patients only living a few months after diagnosis and the condition predicted to become the second most common cancer in Western countries within a decade.

"We identified 32 genes from 10 that are consistently mutated in pancreatic tumours, but further analysis of gene activity revealed four distinct subtypes of tumours," Professor Grimmond said.

"This study demonstrates that pancreatic cancer is better considered as four separate diseases, with different , treatments and underlying genetics.

"Knowing which subtype a patient has would allow a doctor to provide a more accurate prognosis and treatment recommendations.

Importantly Professor Grimmond said there are already cancer drugs, and drugs in development, that can potentially target the parts of the 'damaged machinery' driving pancreatic cancers to start.

For example some strains of pancreatic cancer are unexpectedly associated with mutations normally associated with colon cancer or leukaemia and for which experimental drugs are available or in development. Other pancreatic cancers bear strong similarities to some bladder and lung cancers and we can start to draw on that knowledge to improve treatments," he says.

In a world first, the team performed an integrated genomic analysis, meaning they combined the results of several techniques to examine not only the genetic code, but also variations in structure and gene activity, revealing more information than ever before about the damage that leads to .

This study builds on earlier studies performed by the team as part of the International Cancer Genome Consortium (ICGC).

Explore further: Pancreatic cancer has four distinct types

More information: Genomic analyses identify molecular subtypes of pancreatic cancer, Nature, DOI: 10.1038/nature16965

Related Stories

Pancreatic cancer has four distinct types

February 27, 2015
Researchers have found that pancreatic cancer can be split into four unique types, a discovery that could be used to improve treatments for the disease, according to a study published in Nature.

Plant extract shows promise in treating pancreatic cancer

February 11, 2016
A natural extract derived from India's neem tree could potentially be used to treat pancreatic cancer, according to a new study in the journal Scientific Reports.

Unmasking the deadly secrets of pancreatic cancer

October 25, 2012
(Medical Xpress)—A large-scale study that defines the complexity of underlying mutations responsible for pancreatic cancers in more than 100 patients was published in Nature.

Genomic sequence reveals new treatment options for pancreatic cancer

February 27, 2015
An international project assisted by researchers from The University of Western Australia has offered new hope to patients with pancreatic cancer.

Body's cancer defences hijacked to make pancreatic and lung cancers more aggressive

April 2, 2015
Cancer Research UK scientists have discovered that a vital self-destruct switch in cells is hijacked - making some pancreatic and non small cell lung cancers more aggressive, according to research published in Cancer Cell ...

Diabetes drug found not to cause pancreatic cancer

February 23, 2016
The use of incretin-based drugs is not associated with an increased risk of pancreatic cancer in patients with type 2 diabetes, according to a study published in the latest issue of the British Medical Journal (BMJ). The ...

Recommended for you

Retaining one normal BRCA gene in breast, ovarian cancers influences patient survival

August 22, 2017
Determining which cancer patients are likely to be resistant to initial treatment is a major research effort of oncologists and laboratory scientists. Now, ascertaining who might fall into that category may become a little ...

Zebrafish larvae could be used as 'avatars' to optimize personalized treatment of cancer

August 21, 2017
Portuguese scientists have for the first time shown that the larvae of a tiny fish could one day become the preferred model for predicting, in advance, the response of human malignant tumors to the various therapeutic drugs ...

Scientists discover vitamin C regulates stem cell function, curbs leukemia development

August 21, 2017
Not much is known about stem cell metabolism, but a new study from the Children's Medical Center Research Institute at UT Southwestern (CRI) has found that stem cells take up unusually high levels of vitamin C, which then ...

Searching for the 'signature' causes of BRCAness in breast cancer

August 21, 2017
Breast cancer cells with defects in the DNA damage repair-genes BRCA1 and BRCA2 have a mutational signature (a pattern of base swaps—e.g., Ts for Gs, Cs for As—throughout a genome) known in cancer genomics as "Signature ...

How a non-coding RNA encourages cancer growth and metastasis

August 21, 2017
A mechanism that pushes a certain gene to produce a non-coding form of RNA instead of its protein-coding alternative can promote the growth of cancer, report researchers at the Medical University of South Carolina (MUSC) ...

Spaser can detect, kill circulating tumor cells to prevent cancer metastases, study finds

August 21, 2017
A nanolaser known as the spaser can serve as a super-bright, water-soluble, biocompatible probe capable of finding metastasized cancer cells in the blood stream and then killing these cells, according to a new research study.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.